Fluidigm Newswire

Comprehensive Real-Time News Feed for Fluidigm.

Results 1 - 20 of 67 in Fluidigm

  1. Fluidigm Receives Buy Rating from Cantor FitzgeraldRead the original story

    Monday May 11 | AmericanBankingNews.com

    ... Fitzgerald's price target would suggest a potential upside of 52.34% from the company's current price. Shares of Fluidigm ( NASDAQ:FLDM ) traded up 2.30% on Monday, hitting $27.57. 1,053,454 shares of the company's stock traded hands. Fluidigm has a ...

    Comment?

  2. Analysts' Recent Ratings Changes for FluidigmRead the original story

    Monday May 11 | AmericanBankingNews.com

    5/8/2015 - Fluidigm 's EPS estimates were cut by analysts at Leerink Swann. They now have a "positive" rating and a $45.00 price target on the stock. They previously had a $52.00 price target on the stock. They wrote, "We believe the secular outlook ...

    Comment?

  3. Mizuho Lowers Fluidigm to NeutralRead the original story

    Saturday May 9 | AmericanBankingNews.com

    ... $50.00. Mizuho's price objective points to a potential upside of 11.32% from the company's current price. Shares of Fluidigm ( NASDAQ:FLDM ) traded down 28.00% during mid-day trading on Friday, hitting $26.95. The stock had a trading volume of ...

    Comment?

  4. Fluidigm Corporation (FLDM) CEO Gajus Worthington on Q1 2015 Results -- Earnings Call TranscriptRead the original story w/Photo

    Thursday May 7 | Seeking Alpha

    Welcome to the Fluidigm First Quarter 2015 Financial Results Conference Call. [Operator Instructions].

    Comment?

  5. Fluidigm Corporation Reports Q1 2015 Financial ResultsRead the original story

    Thursday May 7 | BioSpace

    Fluidigm Corporation today announced its financial results for the first quarter ended March 31, 2015. Total revenue for the first quarter of 2015 was $26.7 million, an increase of 4% from $25.7 million in the first quarter of 2014, and an increase of 10% on a constant-currency basis.

    Comment?

  6. Fluidigm Corporation Appoints General Manager Of Production Genomics BusinessRead the original story

    Thursday May 7 | BioSpace

    Fluidigm Corporation has recruited industry veteran Steven C. McPhail to lead its new organization specifically focused on serving its production genomics customers. Production genomics remains a key strategic opportunity for Fluidigm to diversify the company's product lines and end-customer mix.

    Comment?

  7. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday May 7 | Business Wire

    ... CSII), featured two-year data from its ORBIT II study of the company's Diamondback 360A Coronary Orbital At... )--Fluidigm Corporation (NASDAQ:FLDM) has recruited industry veteran Steven C. McPhail to lead its new organization specifically focused ...

    Comment?

  8. Fluidigm Reports Q1 2015 Financial ResultsRead the original story

    Thursday May 7 | Freshnews

    ... currency had a more negative impact than we assumed at the beginning of the year," said Gajus Worthington, Fluidigm President and Chief Executive Officer. "Although disappointed with our performance in the first quarter, we believe our overall ...

    Comment?

  9. Fluidigm Appoints Steve McPhail General Manager of Production Genomics BusinessRead the original story

    Thursday May 7 | Freshnews

    Fluidigm Corporation has recruited industry veteran Steven C. McPhail to lead its new organization specifically focused on serving its production genomics customers. Production genomics remains a key strategic opportunity for Fluidigm to diversify the company's product lines and end-customer mix.

    Comment?

  10. Fluidigm Corporation To Announce Q1 2015 Financial Results And Host Conference Call For InvestorsRead the original story

    Wednesday Apr 29 | BioSpace

    Fluidigm Corporation will report its first quarter 2015 financial results on May 7, 2015, after close of market. Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a conference call at 2:00 p.m. PDT on May 7, 2015, to discuss first quarter 2015 financial results and operating activities.

    Comment?

  11. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Apr 30 | Business Wire

    Stratos Card combines cr... )--Jacada Ltd., today reported financial results for the year ended December 31, 2014 showing revenue growth, new intellectual property patents, and additi... )--Fluidigm Corporation will report its first quarter 2015 financial results on May 7, 2015, after close of market.

    Comment?

  12. Fluidigm to Announce Q1 2015 Financial Results and Host Conference Call for InvestorsRead the original story

    Thursday Apr 30 | Freshnews

    Fluidigm Corporation will report its first quarter 2015 financial results on May 7, 2015, after close of market. Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a conference call at 2:00 p.m. PDT on May 7, 2015, to discuss first quarter 2015 financial results and operating activities.

    Comment?

  13. Evaluation of In Vitro Biotransformation Using HepaRG Cells to...Read the original story

    Friday Apr 24 | U.S. Environmental Protection Agency

    ... concentration-response for 48 hours in a 96-well plate. The expression of 93 genes was profiled via qPCR using Fluidigm 96.96 dynamic arrays. To leverage the xenobiotic metabolism competency of the cells, these results were combined with morphologic ...

    Comment?

  14. Insider Selling: Fluidigm EVP Sells $124,890.00 in StockRead the original story

    Apr 4, 2015 | AmericanBankingNews.com

    Fluidigm EVP Robert C. Jones sold 3,000 shares of the company's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $41.63, for a total transaction of $124,890.00.

    Comment?

  15. Multiplexed locus-specific analysis of DNA methylation in single cellsRead the original story w/Photo

    Mar 26, 2015 | Nature Protocols

    ... primer sets (Steps 8 and 9); (iv) readout of DNA methylation states using locus-specific qPCR performed on the Fluidigm Biomark system (Steps 10-18); and (v) analysis of the amplification data (Step 19). ( a ) The workflow for the Fluidigm qPCR ...

    Comment?

  16. 5AM Ventures backs eHealth startup Pear TherapeuticsRead the original story w/Photo

    Mar 5, 2015 | PE Hub

    ... companies and its successful realizations include Achaogen, Alexza Pharmaceuticals, DVS Sciences (sold to Fluidigm), Envoy Therapeutics (sold to Takeda), Flexion Therapeutics, Ikaria (sold to Madison Dearborn), Ilypsa (sold to Amgen), Incline ...

    Comment?

  17. Pear Therapeutics Closes FinancingRead the original story w/Photo

    Mar 19, 2015 | PRWeb

    ... companies and its successful realizations include Achaogen, Alexza Pharmaceuticals, DVS Sciences (sold to Fluidigm), Envoy Therapeutics (sold to Takeda), Flexion Therapeutics, Ikaria (sold to Madison Dearborn), Ilypsa (sold to Amgen), Incline ...

    Comment?

  18. Fluidigm Corporation (FLDM) - Medical Equipment - Deals and Alliances Profile - New Study ReleasedRead the original story

    Mar 7, 2015 | PR-inside.com

    2015-03-07 15:38:54 - New Medical Devices market report from GlobalData: "Fluidigm Corporation (FLDM) - Medical Equipment - Deals and Alliances Profile" Fluidigm Corporation (Fluidigm) is a biotechnology company. The company manufactures and markets ...

    Comment?

  19. Genentech Release: SNP Trace Panel Proves To Be A High-Throughput,...Read the original story

    Feb 25, 2015 | BioSpace

    Genentech Release: SNP Trace Panel Proves To Be A High-Throughput, Cost-Effective SNP-Based Platform For Profiling Human Tissue And Cell Lines PLOS ONE Paper Profiles 907 Human Cell Lines SOUTH SAN FRANCISCO, Calif.-- --Researchers at Genentech, a member of the Roche Group, and Fluidigm Corporation have used the Fluidigm SNP Tracea panel to generate a database of SNP profiles for 907 cancer cell lines as a resource for cell line authentication. This information was published in the current issue of the journal PLOS ONE in a paper entitled "Human biosample authentication using the high-throughput, cost-effective SNP Tracea system" .

    Comment?

  20. Advanced Digital PCR Detection Methods to Guarantee Better Clinical...Read the original story w/Photo

    Feb 24, 2015 | PRWeb

    ... market at a global level. The most prominent vendors operating in this market space are RainDance Technologies, Fluidigm, Thermo Fisher Scientific, and Bio-Rad Laboratories. Other participants of the dPCR market include Bibby Scientific, Exiqon, ...

    Comment?